Circulating adiponectin in humans has been found to correlate inversely with insulin resistance and T2DM.33 However, this relationship is inconsistent, with other studies that found elevated adiponectin increased T2DM risk and CVD mortality.34,35. Here, ADIPOQ is linked to type 2 diabetes mellitus.